First-line taxane-versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study
JAAD International
· Elsevier
Аннотация
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kohei Otsubo, Yoshimasa Shiraishi, Takayuki Shimose, Keita Miura, Daiki Murata, Taichi Miyawaki, Hidehito Horinouchi, Taishi Harada, Yuko Tsuchiya-Kawano, Ritsu Ibusuki, Mikiko Hashisako, Yoshinao Oda, Isamu Okamoto
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Дерматология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
First-line taxane-versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000422?dgcid=rss_sd_all
First-line taxane-versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study. JAAD International. https://www.sciencedirect.com/science/article/pii/S3117504X26000422?dgcid=rss_sd_all
“First-line taxane-versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study.” JAAD International.
@article{article5824,
title = {First-line taxane-versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000422?dgcid=rss_sd_all}
}